Hyperdrive has integrated Centrifuge’s deSPXA token, representing the Anemoy S&P 500 Index Fund, into its Base lending market. This allows eligible non-U.S. users to borrow USDC using deSPXA as collateral, expanding the token's use beyond trading and lending on other platforms. The move enhances liquidity options for tokenized equity exposure without selling assets, limited to non-U.S. persons under Regulation S. This integration supports the growth of real-world asset-backed DeFi credit markets.
Hyperdrive's integration of Centrifuge’s deSPXA token offers new collateral options for USDC loans. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 07, 2026 21:23 WIB: out of 50 major cryptocurrencies, 5 rose and 43 fell. Notable moves include SXP at Rp37 with a -46.27% change, ENJ at Rp523 down -11.93%, and EGLD at Rp71,582 down -11.73%. Typical hold times range from 85 to 104 days, with varied buy-sell activity.
BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...
Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...
Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...
Jito Labs has introduced JTX, a new self-custodial trading platform on the Solana blockchain. The platform supports spot trading of tokens, memecoins, tokenized equities, and ETFs, providing professional-grade execution tools. This launch aims to emp...
Evernorth's $1 billion XRP-only fund, initially set to debut on NASDAQ on October 8, 2026, has been postponed to October 12 due to an administrative delay. This delay does not affect the recent merger approval by Armada II shareholders or the fund's ...
